The	DT
role	NN
of	IN
halofuginone	NN
in	IN
fibrosis	NN
:	:
more	JJR
to	TO
be	VB
explored	VBN
?	.

Fibrosis	NN
,	,
which	WDT
can	MD
be	VB
defined	VBN
as	IN
an	DT
abnormal	JJ
or	CC
excessive	JJ
accumulation	NN
of	IN
extracellular	JJ
matrix	NN
(	(
ECM	NN
)	)
,	,
particularly	RB
fibrillar	JJ
collagens	NNS
,	,
is	VBZ
a	DT
key	JJ
driver	NN
of	IN
progressive	JJ
organ	NN
dysfunction	NN
in	IN
many	JJ
inflammatory	JJ
and	CC
metabolic	JJ
diseases	NNS
,	,
including	VBG
idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
,	,
cirrhosis	NN
,	,
nephropathy	NN
,	,
and	CC
oral	JJ
submucous	JJ
fibrosis	NN
(	(
OSF	NN
)	)
.	.

It	PRP
has	VBZ
been	VBN
estimated	VBN
to	TO
contribute	VB
to	TO
45	CD
%	NN
of	IN
deaths	NNS
in	IN
the	DT
developed	JJ
world	NN
.	.

Therefore	RB
,	,
agents	NNS
that	WDT
target	VBP
specific	JJ
fibrotic	JJ
pathways	NNS
,	,
with	IN
the	DT
consequence	NN
of	IN
slowing	VBG
,	,
arresting	VBG
,	,
or	CC
even	RB
reversing	VBG
the	DT
progression	NN
of	IN
tissue	NN
fibrogenesis	NN
,	,
are	VBP
urgently	RB
needed	VBN
.	.

7-Bromo-6-chloro-3	NN
-	:
[	(
3	LS
-	:
(	(
3-hydroxy-2-piperidinyl	JJ
)	)
-2-oxopropyl	NN
]	)
-4	CD
(	(
3H	NN
)	)
-	:
quinazolinone	NN
(	(
halofuginone	NN
)	)
,	,
an	DT
analog	NN
of	IN
febrifugine	NN
,	,
which	WDT
specifically	RB
targets	VBZ
the	DT
pathogenesis	NN
of	IN
ECM	NN
proteins	NNS
,	,
inhibits	VBZ
tissue	NN
fibrosis	NN
and	CC
regeneration	NN
and	CC
even	RB
affects	VBZ
the	DT
development	NN
of	IN
tumors	NNS
in	IN
various	JJ
tissues	NNS
.	.

Four	CD
modes	NNS
of	IN
actions	NNS
of	IN
halofuginone	NN
against	IN
fibrosis	NN
have	VBP
been	VBN
presented	VBN
:	:
1	LS
)	)
Inhibition	NN
of	IN
mothers-against-decapentaplegic-homolog-3	NN
(	(
Smad3	NN
)	)
phosphorylation	NN
downstream	RB
of	IN
the	DT
TGF-b	NN
signaling	NN
pathway	NN
,	,
2	LS
)	)
reduction	NN
of	IN
collagen	NN
amounts	NNS
,	,
3	LS
)	)
decreases	VBZ
in	IN
ECM	NN
protein	NN
,	,
and	CC
4	LS
)	)
selective	JJ
prevention	NN
of	IN
Th17	NN
cell	NN
differentiation	NN
.	.

In	IN
this	DT
review	NN
,	,
we	PRP
will	MD
mainly	RB
focus	VB
on	IN
the	DT
rationale	NN
for	IN
halofuginone	NN
against	IN
fibrosis	NN
.	.

